NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 175 filers reported holding NOVAVAX INC in Q3 2016. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $130,000 | -71.0% | 240,221 | -1.6% | 0.00% | -66.7% |
| Q4 2018 | $448,000 | +229.4% | 244,100 | +237.2% | 0.01% | +200.0% |
| Q3 2018 | $136,000 | +17.2% | 72,400 | -17.0% | 0.00% | 0.0% |
| Q2 2018 | $116,000 | -34.8% | 87,200 | +2.3% | 0.00% | 0.0% |
| Q1 2018 | $178,000 | +102.3% | 85,200 | +19.8% | 0.00% | +100.0% |
| Q4 2017 | $88,000 | +8.6% | 71,100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $81,000 | +636.4% | 71,100 | +633.0% | 0.00% | – |
| Q2 2017 | $11,000 | -78.4% | 9,700 | -76.0% | 0.00% | -100.0% |
| Q1 2017 | $51,000 | -90.2% | 40,400 | -90.2% | 0.00% | -83.3% |
| Q4 2016 | $518,000 | -49.9% | 411,800 | -17.1% | 0.01% | -60.0% |
| Q3 2016 | $1,033,000 | -55.1% | 496,800 | +56.8% | 0.02% | -57.1% |
| Q2 2016 | $2,302,000 | +1105.2% | 316,800 | +29125.1% | 0.04% | +600.0% |
| Q1 2016 | $191,000 | – | 1,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |